Loss of Response of Adalimumab Biosimilar vs Adalimumab Original, in Inflammatory Bowel Disease.

Clinical trial NCT04131322 · TERMINATED

Trial details

NCT number: NCT04131322
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Crohn Disease Ulcerative Colitis

Start date: 2019-10-10
Primary completion: 2020-06-08
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.